Infectious Diseases News and Research

RSS

Medivir initiates TMC649128 phase Ib trial in chronic hepatitis C

Medivir AB, the emerging research-based specialty pharmaceutical company focused on infectious diseases, today announces the start of a phase Ib clinical trial with TMC649128 intended for the treatment of chronic hepatitis C virus (HCV) infection.

22 Jun 2011

Public-private partnerships leading to successes in HIV treatment and prevention

The recent achievements in studies looking at treatment as prevention "were only made possible by the partnership between publicly funded scientists and private drug companies," Ward Cates, president of research at FHI; Salim Abdool Karim, director of the Centre for the AIDS Program of Research in South Africa; and Myron Cohen, director of the UNC Division of Infectious Disease and the UNC Institute for Global Health and Infectious Disease, write in an opinion piece in the Huffington Post.

21 Jun 2011

Viewpoints: Compromises on fixing Medicare?; 'progress' on AIDS; working families falling behind

Fixing Medicare should not compromise patient care. The president's health care bill created the controversial Independent Payment Advisory Board. This panel of unelected bureaucrats, whose sole purpose is to decide whether to offer Medicare benefits based on a budget, could lead to government rationing of care.

21 Jun 2011

bioMD (BOD) announces new MD, new Chairman and Board

bioMD Limited (ASX:BOD), a company with assets in regenerative tissue engineering technologies today announced the appointment of a new Chairman, a new MD and other changes to its Board. This follows shareholder approval for the acquisition of Allied Medical Ltd., a company that specialises in the sales, distribution and commercialisation of medical technologies.

20 Jun 2011

CarePoint acquires infusion business of ArTex Medical

Waud Capital Partners announced that its portfolio company, CarePoint Partners, has acquired the infusion business of ArTex Medical, Inc., marking its 13th acquisition in under four years.

20 Jun 2011

WHO special issue addresses economic burden of dengue in the Americas, Africa and Asia

The ten studies in this special issue document the substantial and growing burden of dengue in the Americas, Africa and Asia, and the burden of a chikungunya outbreak in India.

18 Jun 2011

UTHealth receives $1M FEMA grant to examine link between Ad-36 infection, obesity

Researchers at The University of Texas Health Science Center at Houston (UTHealth) have been awarded nearly $1 million to investigate Adenovirus-36 (Ad-36) infection as a novel risk factor for obesity.

17 Jun 2011

Scientists uncover how immune system responds to invading anthrax bacteria

Scientists at the University of California, San Diego School of Medicine and Skaggs School of Pharmacy and Pharmaceutical Sciences have uncovered how the body's immune system launches its survival response to the notorious and deadly bacterium anthrax.

17 Jun 2011

Serious RSV infections may occur in previously healthy infants and children

For most parents, respiratory syncytial virus (RSV) isn't a familiar term. But it's a common cause of serious respiratory infections with a major impact on the health of infants and young children worldwide, according to a special CDC Review Article in the June issue of The Pediatric Infectious Disease Journal. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

16 Jun 2011

Scientists discover new cell type in the immune system

A team of Australian scientists has discovered a new type of cell in the immune system. The new cell type, a kind of white blood cell, belongs to a family of T-cells that play a critical role in protection against infectious disease.

16 Jun 2011

Inviragen commences INV21 Phase 1 trial against Hand, Foot and Mouth Disease

Inviragen announced today the initiation of the first clinical trial of the Company's proprietary Hand, Foot and Mouth Disease (HFMD) investigational vaccine, INV21, a highly purified virus particle preparation designed to protect against HFMD caused by enterovirus 71.

16 Jun 2011

Simple and cheap Syphilis test could save the lives of millions of babies

Syphilis, a sexually transmitted disease that has been a taboo for decades, kills an estimated one million newborn and stillborn babies every year. However a simple test for every pregnant woman followed by antibiotics for those infected would stop the deaths.

16 Jun 2011

Novartis Bexsero pivotal study data on meningococcal serogroup B presented at ESPID

New data from a pivotal study in more than 1,800 infants show that Novartis candidate vaccine Bexsero induces a robust immune response to meningococcal serogroup B when given alone or when co-administered with other routine vaccines.

15 Jun 2011

Science Speaks series interviews key players in global AIDS fight

In the final installment of a series recognizing the 30th anniversary of AIDS on the Center for Global Health Policy's "Science Speaks" blog, John Donnelly interviews Warren "Buck" Buckingham, director of the Office of AIDS Relief at the Peace Corps, about his work in the field.

14 Jun 2011

STCEID to establish Center of Excellence in Infection Genomics

The South Texas Center for Emerging Infectious Diseases at The University of Texas at San Antonio announced today it will receive $4.6 million over the next five years from the U.S. Department of Defense's Army Research Office to establish a Center of Excellence in Infection Genomics to support microbiology research, teaching and outreach activities aligned with Army priorities.

13 Jun 2011

National, continental health center coordination lacking in E. coli outbreak response

During the handling of the E. coli outbreak in Germany, "coordination of the German public health response seems to have been utterly absent," a Lancet editorial states, adding, "But one should also ask: where was the European Centres of Disease Prevention and Control? … From the public's point of view, no visible collaboration seems to have taken place."

13 Jun 2011

New opportunities to save another 6.4 million lives

Vaccinating children around the world against infectious diseases has saved the lives of millions over the past several decades. Now new opportunities exist to overcome remaining challenges-and save another 6.4 million lives over the current decade, according articles in the June 2011 edition of Health Affairs. The issue was produced under the journal's grant from the Bill & Melinda Gates Foundation.

10 Jun 2011

Mortality from all causes higher among hepatitis C-infected patients, study finds

Although liver-related mortality among those infected with hepatitis C is well-documented, little is known about deaths in these patients that are not related to liver problems. A new study published in Clinical Infectious Diseases and now available online sought to determine mortality from all causes, including liver- and non-liver related deaths among hepatitis C patients in the general U.S. population. The analysis found mortality from all causes to be higher in these patients.

10 Jun 2011

NIAID awards Biota $2.9M grant for development of lead candidate for C. difficile

Biota Holdings Limited advises that its wholly owned subsidiary, Biota Scientific Management Pty Ltd, has been awarded a grant to fund the preclinical development of a lead candidate for the treatment of Clostridium difficile (C. difficile).

10 Jun 2011

Researchers and advocates form new vaccine foundation

Researchers and "advocates for all vaccine research today launched yet another effort to increase funding and coordination," ScienceInsider reports. The Foundation for Vaccine Research "has recruited a board stacked with several prominent HIV/AIDS researchers," the article notes.

10 Jun 2011

Infectious Diseases News and Research

Medivir initiates TMC649128 phase Ib trial in chronic hepatitis C

Public-private partnerships leading to successes in HIV treatment and prevention

Viewpoints: Compromises on fixing Medicare?; 'progress' on AIDS; working families falling behind

bioMD (BOD) announces new MD, new Chairman and Board

CarePoint acquires infusion business of ArTex Medical

WHO special issue addresses economic burden of dengue in the Americas, Africa and Asia

UTHealth receives $1M FEMA grant to examine link between Ad-36 infection, obesity

Scientists uncover how immune system responds to invading anthrax bacteria

Serious RSV infections may occur in previously healthy infants and children

Scientists discover new cell type in the immune system

Inviragen commences INV21 Phase 1 trial against Hand, Foot and Mouth Disease

Simple and cheap Syphilis test could save the lives of millions of babies

Novartis Bexsero pivotal study data on meningococcal serogroup B presented at ESPID

Science Speaks series interviews key players in global AIDS fight

STCEID to establish Center of Excellence in Infection Genomics

National, continental health center coordination lacking in E. coli outbreak response

New opportunities to save another 6.4 million lives

Mortality from all causes higher among hepatitis C-infected patients, study finds

NIAID awards Biota $2.9M grant for development of lead candidate for C. difficile

Researchers and advocates form new vaccine foundation

NGS for Infectious Disease Surveillance eBook

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Latest News